(Q34675470)

3 August 2017

title

Keratinocyte-specific deletion of the receptor RAGE modulates the kinetics of skin inflammation in vivo (English)

1 reference

3 August 2017

0 references

1 reference

Julia S Leibold

1

1 reference

3 August 2017

Astrid Riehl

2

1 reference

3 August 2017

Jan Hettinger

3

1 reference

3 August 2017

Michael Durben

4

1 reference

3 August 2017

Jochen Hess

5

1 reference

3 August 2017

Peter Angel

6

1 reference

3 August 2017

language of work or name

English

0 references

publication date

17 April 2013

1 reference

Journal of Investigative Dermatology

3 August 2017

published in

1 reference

3 August 2017

volume

133

1 reference

3 August 2017

issue

10

1 reference

3 August 2017

page(s)

2400-2406

1 reference

RAGE: a multi-ligand receptor unveiling novel insights in health and disease

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.185

7 January 2021

S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.185

7 January 2021

S100B/RAGE-dependent activation of microglia via NF-kappaB and AP-1 Co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.185

7 January 2021

Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.185

7 January 2021

RAGE (receptor for advanced glycation end products): a central player in the inflammatory response

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.185

7 January 2021

Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.185

7 January 2021

RAGE and ICAM-1 differentially control leukocyte recruitment during acute inflammation in a stimulus-dependent manner

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.185

7 January 2021

RAGE signaling sustains inflammation and promotes tumor development

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.185

7 January 2021

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.185

7 January 2021

beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.185

7 January 2021

Advanced glycation end products-induced apoptosis attenuated by PPARdelta activation and epigallocatechin gallate through NF-kappaB pathway in human embryonic kidney cells and human mesangial cells.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.185

7 January 2021

Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.185

7 January 2021

Effects of filaggrin breakdown products on the growth and maturation of keratinocytes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.185

7 January 2021

TNF-alpha inhibits macrophage clearance of apoptotic cells via cytosolic phospholipase A2 and oxidant-dependent mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.185

7 January 2021

The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyl

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.185

7 January 2021

The role of reactive oxygen species in TNFalpha-dependent expression of the receptor for advanced glycation end products in human umbilical vein endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.185

7 January 2021

Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.185

7 January 2021

Identification of the Rage-dependent gene regulatory network in a mouse model of skin inflammation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.185

7 January 2021

The mouse keratin 6 isoforms are differentially expressed in the hair follicle, footpad, tongue and activated epidermis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.185

7 January 2021

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.185

7 January 2021

Phagocyte partnership during the onset and resolution of inflammation.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.185

7 January 2021

The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.185

7 January 2021

RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.185

7 January 2021

The pathophysiology of tumor necrosis factors

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.185

7 January 2021

Gene from a psoriasis susceptibility locus primes the skin for inflammation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.185

7 January 2021

Dermal injection of immunocytes induces psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.185

7 January 2021

Identifiers

DOI

10.1038/JID.2013.185

1 reference

Dimensions Publication ID

3 August 2017

1033874474

0 references

1 reference